|
EP0776218A2
(en)
*
|
1994-03-15 |
1997-06-04 |
Prizm Pharmaceuticals, Inc. |
Heparin-binding growth factors for gene therapy and anterior eye disorders
|
|
US20080076706A1
(en)
|
1997-07-14 |
2008-03-27 |
Bolder Biotechnology, Inc. |
Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
|
|
US7153943B2
(en)
|
1997-07-14 |
2006-12-26 |
Bolder Biotechnology, Inc. |
Derivatives of growth hormone and related proteins, and methods of use thereof
|
|
ATE375363T1
(de)
|
1997-07-14 |
2007-10-15 |
Bolder Biotechnology Inc |
Derivate des wachstumshormons und verwandte proteine
|
|
US7495087B2
(en)
|
1997-07-14 |
2009-02-24 |
Bolder Biotechnology, Inc. |
Cysteine muteins in the C-D loop of human interleukin-11
|
|
WO1999040771A2
(en)
|
1998-02-13 |
1999-08-19 |
Selective Genetics, Inc. |
Concurrent flow mixing for preparing compositions comprising gene therapy vectors
|
|
US7157418B1
(en)
|
1998-07-22 |
2007-01-02 |
Osprey Pharmaceuticals, Ltd. |
Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
|
|
WO2000040723A2
(en)
*
|
1999-01-04 |
2000-07-13 |
University Of Vermont And State Agricultural College |
Methods and products for delivering nucleic acids
|
|
US6903077B1
(en)
|
1999-01-04 |
2005-06-07 |
University Of Vermont And State Agricultural College |
Methods and products for delivering nucleic acids
|
|
US8288126B2
(en)
|
1999-01-14 |
2012-10-16 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
|
BR122013003013B8
(pt)
*
|
1999-01-14 |
2021-07-06 |
Bolder Biotechnology Inc |
proteína isolada monopeguilada do hormônio do crescimento e método para sua obtenção
|
|
AU5088600A
(en)
*
|
1999-06-03 |
2000-12-28 |
Bioinnovation Limited |
Gene therapy products
|
|
US6506365B1
(en)
*
|
2000-09-25 |
2003-01-14 |
Baxter Aktiengesellschaft |
Fibrin/fibrinogen binding conjugate
|
|
JP2002161049A
(ja)
*
|
2000-11-28 |
2002-06-04 |
Terumo Corp |
血管内膜肥厚抑制剤
|
|
GB0209896D0
(en)
|
2002-04-30 |
2002-06-05 |
Molmed Spa |
Conjugate
|
|
US7270983B1
(en)
*
|
2004-02-19 |
2007-09-18 |
Research Foundation Of The University Of Central Florida, Inc. |
Messenger RNA profiling: body fluid identification using multiplex reverse transcription-polymerase chain reaction (RT-PCR)
|
|
PL2043662T3
(pl)
*
|
2006-07-26 |
2016-03-31 |
Intrexon Corp |
Sposoby i kompozycje do leczenia choroby
|
|
CA2796459C
(en)
|
2010-04-16 |
2016-05-24 |
Salk Institute For Biological Studies |
Methods for treating metabolic disorders using fgf-1
|
|
WO2015061331A1
(en)
|
2013-10-21 |
2015-04-30 |
Salk Institute For Biological Studies |
Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use
|
|
WO2017127493A1
(en)
*
|
2016-01-22 |
2017-07-27 |
Salk Institute For Biological Studies |
Fgf2 truncations and mutants and uses thereof
|
|
IL299359A
(en)
*
|
2020-06-24 |
2023-02-01 |
Sapreme Tech Bv |
Saponin derivatives and medicinal preparations containing them
|
|
WO2021261996A2
(en)
*
|
2020-06-24 |
2021-12-30 |
Sapreme Technologies B.V. |
Nhs-based saponin conjugates
|
|
CH716377B1
(it)
*
|
2020-08-05 |
2020-12-30 |
Contrad Swiss Sa |
Idrogel ad applicazione topica efficace nel prevenire e/o attenuare la degenerazione della cartilagine.
|